Disclosure Of Interests In Other Entities [Text Block]

Innate Pharma - Filing #858132

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	Méthode de consolidation	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	139 831 EUR	—	—	—	—	—	—	—	—	—	—	—	138 256 EUR	—	—	—	—	—	—
Non-current assets	68 033 EUR	—	—	—	—	—	—	—	—	—	—	—	129 241 EUR	—	—	—	—	—	—
Current liabilities	41 338 EUR	—	—	—	—	—	—	—	—	—	—	—	79 886 EUR	—	—	—	—	—	—
Non-current liabilities	112 374 EUR	—	—	—	—	—	—	—	—	—	—	—	80 169 EUR	—	—	—	—	—	—
Revenue	—	—	—	57 674 EUR	—	—	—	—	—	—	—	—	—	—	—	—	24 703 EUR	—	—
Profit (loss)	—	— EUR	— EUR	58 103 EUR	— EUR	58 103 EUR	— EUR	— EUR	— EUR	— EUR	52 809 EUR	— EUR	—	— EUR	— EUR	— EUR	52 809 EUR	— EUR	—
Comprehensive income	—	— EUR	362,000 EUR	57 741 EUR	— EUR	58 103 EUR	— EUR	— EUR	— EUR	— EUR	52 809 EUR	101,000 EUR	—	— EUR	— EUR	— EUR	52 708 EUR	— EUR	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Profit (loss) from continuing operations	—	—	—	57 972 EUR	—	—	—	—	—	—	—	—	—	—	—	—	45 478 EUR	—	—
Profit (loss) from discontinued operations	—	—	—	131,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	7 331 EUR	—	—
Other comprehensive income	—	—	—	362,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	101,000 EUR	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	84 225 EUR	—	—	—	—	—	—	—	—	—	—	—	103 756 EUR	—	—	—	—	—	136 792 EUR
Tax expense (income)	—	—	—	— EUR	—	—	—	—	—	—	—	—	—	—	—	—	— EUR	—	—